Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Unusually-High Trading Volume – Here’s Why

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) shares saw unusually-high trading volume on Monday . Approximately 26,203 shares changed hands during trading, an increase of 90% from the previous session’s volume of 13,775 shares.The stock last traded at $18.13 and had previously closed at $18.60.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on TLX shares. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group raised their price objective on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Down 0.7 %

The company’s fifty day moving average price is $16.16.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.